CCL2 and allergic asthma: These results suggest that except for CCL2/MCP1, the lack of PLXND1 in CD11c+ DC does not significantly impact the biosynthesis and release of IL-4, IL-5, IL-13, IL-17A, and IFN-γ in this HDM model of allergic asthma.